Elisabeth Schültke
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Elisabeth Schültke has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
Christian Nemoz
European Synchrotron Radiation Facility (ESRF), 6 rue Horowitz, 38043 Grenoble, France
2 shared publicationsFrancois Esteve
CR INSERM U836-Team 6/ESRF, 6 rue Horowitz, 38043 Grenoble, France
2 shared publicationsGeraldine Le Duc
European Synchrotron Radiation Facility (ESRF), 6 rue Horowitz, 38043 Grenoble, France
2 shared publicationsHerwig Requardt
European Synchrotron Radiation Facility (ESRF), 6 rue Horowitz, 38043 Grenoble, France
2 shared publicationsKotoo Meguro
University of Saskatchewan, Saskatoon, SK, Canada
2 shared publicationsLissa Ogieglo
University of Saskatchewan, Saskatoon, SK, Canada
2 shared publications
Latest Publications
- 31 August 2011
- Published by Elsevier in European Journal of Radiology
- Vol. 79 (2) , 323-327
Dual energy CT at the synchrotron: A piglet model for neurovascular research
- 31 August 2011
- Published by Elsevier in European Journal of Radiology
- Vol. 79 (2) , 323-327
Dual energy CT at the synchrotron: A piglet model for neurovascular research
- 1 March 2010
- Published by Elsevier in European Journal of Radiology
- Vol. 73 (3) , 677-681
Synchrotron-based intra-venous K-edge digital subtraction angiography in a pig model: A feasibility study
- 1 March 2010
- Published by Elsevier in European Journal of Radiology
- Vol. 73 (3) , 677-681
Synchrotron-based intra-venous K-edge digital subtraction angiography in a pig model: A feasibility study
- 8 September 2009
- Published by Springer Nature in Spinal Cord
- Vol. 48 (2) , 112-117
Quercetin in an animal model of spinal cord compression injury: correlation of treatment duration with recovery of motor function
We have shown previously that administration of quercetin after spinal cord injury in a rat model induced significant recovery of motor function. In the same model for spinal cord compression injury, we now have correlated the treatment duration with the extent to which motor function is recovered. Seventy-four male Wistar rats were assigned to eight experimental groups. Mid-thoracic spinal cord injury was produced in the animals of seven groups. Quercetin was administered intraperitoneally in individual doses of 25 micromol kg(-1). Treatment onset was 1 h after the injury. The length of treatment ranged from one single injection to 10 days, with injection frequencies of two or three times daily. BBB (Basso, Beattie and Bresnahan) scores were obtained and tissue preservation at the site of injury was analyzed. None of the untreated control animals recovered motor function sufficient to walk. When quercetin was administered twice daily over a period of either 3 or 10 days, about 50% of the animals recovered sufficient motor function to walk. Stepping/walking (BBB > or =10) were seen in two of six animals receiving only a single injection and in one of the six animal receiving three injections. Surprisingly, none of the animals that received quercetin injections three times daily recovered the ability to walk (all BBB < or = 9). Quercetin administration results in preservation of tissue bridges at the site of injury. Treatment success depends on frequency of administration and overall dose.
- 8 September 2009
- Published by Springer Nature in Spinal Cord
- Vol. 48 (2) , 112-117
Quercetin in an animal model of spinal cord compression injury: correlation of treatment duration with recovery of motor function
We have shown previously that administration of quercetin after spinal cord injury in a rat model induced significant recovery of motor function. In the same model for spinal cord compression injury, we now have correlated the treatment duration with the extent to which motor function is recovered. Seventy-four male Wistar rats were assigned to eight experimental groups. Mid-thoracic spinal cord injury was produced in the animals of seven groups. Quercetin was administered intraperitoneally in individual doses of 25 micromol kg(-1). Treatment onset was 1 h after the injury. The length of treatment ranged from one single injection to 10 days, with injection frequencies of two or three times daily. BBB (Basso, Beattie and Bresnahan) scores were obtained and tissue preservation at the site of injury was analyzed. None of the untreated control animals recovered motor function sufficient to walk. When quercetin was administered twice daily over a period of either 3 or 10 days, about 50% of the animals recovered sufficient motor function to walk. Stepping/walking (BBB > or =10) were seen in two of six animals receiving only a single injection and in one of the six animal receiving three injections. Surprisingly, none of the animals that received quercetin injections three times daily recovered the ability to walk (all BBB < or = 9). Quercetin administration results in preservation of tissue bridges at the site of injury. Treatment success depends on frequency of administration and overall dose.
- 1 May 2009
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 64 (5) , 1001-1005
THEODOR KOCHER'S CRANIOMETER
The first half of the 20th century witnessed the rapid emergence of neurological surgery as a surgical subspecialty. Only few surgeons made a name for themselves equally in general surgery and neurological surgery. One of them was the Swiss surgeon Theodor Kocher (1841-1917). He was honored with the Nobel Prize for his innovative approaches to pathology and surgery of the thyroid gland. Kocher also attracted students from all over the world to his laboratory to study the pathology of neurotrauma and the consequences of increased intracranial pressure on brain function. One of his most interesting contributions to the neurosurgical equipment of his time is a craniometer, used to correlate the location of intracranial pathology to landmarks on the surface of the cranium. Craniometers can be seen as simple forerunners of today's sophisticated stereotactic frames. They contributed significantly to the advancement of neurological surgery, allowing localization of known functional centers as well as lesions of the brain in a 3-dimensional system.
- 1 May 2009
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 64 (5) , 1001-1005
THEODOR KOCHER'S CRANIOMETER
The first half of the 20th century witnessed the rapid emergence of neurological surgery as a surgical subspecialty. Only few surgeons made a name for themselves equally in general surgery and neurological surgery. One of them was the Swiss surgeon Theodor Kocher (1841-1917). He was honored with the Nobel Prize for his innovative approaches to pathology and surgery of the thyroid gland. Kocher also attracted students from all over the world to his laboratory to study the pathology of neurotrauma and the consequences of increased intracranial pressure on brain function. One of his most interesting contributions to the neurosurgical equipment of his time is a craniometer, used to correlate the location of intracranial pathology to landmarks on the surface of the cranium. Craniometers can be seen as simple forerunners of today's sophisticated stereotactic frames. They contributed significantly to the advancement of neurological surgery, allowing localization of known functional centers as well as lesions of the brain in a 3-dimensional system.
- 1 December 2008
- Published by Elsevier in European Journal of Radiology
- Vol. 68 (3) , S142-S146
Memory and survival after microbeam radiation therapy
- 1 December 2008
- Published by Elsevier in European Journal of Radiology
- Vol. 68 (3) , S142-S146
Memory and survival after microbeam radiation therapy